BIG NEWS EVERYONE: Dr. Mark Alberts has the solution to the two-decade-long tPA-in-stroke debate. And he only needed to cite two trials! https://www.medscape.com/viewarticle/896543?src=soc_fb_180517_mscpedt_news_mdscp_tpastroke&faf=1 … The answer's been right in front of us the whole time; it's a shame everyone was just too dumb to realize it.pic.twitter.com/Vm7bFSR5vD
-
-
Yeah Alteplase is made by Genentech which is listed in his disclosures

-
“equal to or greater than $250” is a BIT of an understatement...
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.